GLYNAZAN

Welcome to the Brand page for “GLYNAZAN”, which is offered here for Theophylline sodium glycinate for the symptomatic treatment of bronchial and circulatory disturbances where theophylline therapy is indicated;.

Its status is currently believed to be active. Its class is unavailable. “GLYNAZAN” is believed to be currently owned by “FIRST TEXAS CHEMICAL MANUFACTURING COMPANY”.


Owner:
FIRST TEXAS CHEMICAL MANUFACTURING COMPANY
Owner Details
Description:
THEOPHYLLINE SODIUM GLYCINATE FOR THE SYMPTOMATIC TREATMENT OF BRONCHIAL AND CIRCULATORY DISTURBANCES WHERE THEOPHYLLINE THERAPY IS INDICATED;
Categories: THEOPHYLLINE SODIUM GLYCINATE FOR